Plantago major

Plantago major contains mucilage polysaccharides and iridoid glycosides like aucubin that provide anti-inflammatory and wound healing properties. The mucilage forms protective barriers on damaged tissues while aucubin inhibits inflammatory mediators.

Origin & History

Plantago major, commonly known as broadleaf plantain or greater plantain, is a perennial herbaceous plant in the Plantaginaceae family native to Europe, Asia, and North America, now widely naturalized globally. The aerial parts (leaves) and seeds are primarily used medicinally, with extracts typically obtained through aqueous or hydroalcoholic methods, yielding phenolic compounds, mucilages, and flavonoids.

Historical & Cultural Context

Plantago major has been used globally in traditional medicine for millennia, including in European, Persian, Ayurvedic, and Indigenous systems for wounds, ulcers, respiratory issues (cough, bronchitis), inflammation, and gastrointestinal disorders. Local Iranian traditional use for pressure ulcers and lesions has been validated through modern clinical research.

Health Benefits

• Wound healing and pressure ulcer resolution - RCT (n=130) showed topical formulation significantly improved stage 1 pressure ulcers vs. control over 14 days (strong evidence)
• Ulcerative colitis symptom relief - RCT (n=51) found 3600 mg/day roasted seeds reduced abdominal tenderness, reflux, and pain over 8 weeks (moderate evidence)
• Acute bronchitis improvement - RCT (n=80) demonstrated 30 ml/day syrup lowered Bronchitis Severity Scale scores and improved quality of life after 10 days (strong evidence)
• Diabetic nephropathy management - RCT (n=60) showed 20 g/day seed powder with losartan reduced proteinuria from 165 to 136 mg over 60 days (moderate evidence)
• Non-alcoholic fatty liver disease (NAFLD) support - RCT (n=63) found 4 g/day seeds reduced ALT, AST, and triglycerides over 12 weeks (moderate evidence)

How It Works

Plantago major's mucilage polysaccharides form protective hydrogels on wound surfaces, promoting epithelial cell migration and collagen synthesis. The iridoid glycoside aucubin inhibits nuclear factor-kappa B (NF-κB) signaling, reducing pro-inflammatory cytokine production. Additional compounds like plantamajoside modulate prostaglandin E2 synthesis through cyclooxygenase pathway inhibition.

Scientific Research

Multiple randomized controlled trials demonstrate Plantago major's clinical efficacy, including studies on pressure ulcers (PMID: 33548748), ulcerative colitis (PMID: 34265576), acute bronchitis (PMID: 39359439), diabetic nephropathy (PMID: 38797623), and NAFLD (n=74). A quasi-experimental study also showed comparable healing to conventional treatment for second-degree burns (PMIDs: 35966146, 9359829), though no meta-analyses of human RCTs were identified.

Clinical Summary

A randomized controlled trial (n=130) demonstrated that topical Plantago major formulations significantly improved stage 1 pressure ulcer healing versus control over 14 days, showing strong evidence for wound healing applications. For digestive health, an RCT (n=51) found 3600 mg daily of roasted seeds reduced abdominal tenderness and reflux symptoms in ulcerative colitis patients. However, the digestive study appears incomplete in available data, and more robust trials are needed to fully establish internal use benefits. Current evidence is strongest for topical wound healing applications.

Nutritional Profile

Plantago major leaves (per 100 g fresh weight, approximate values): Water 80–85 g; Protein 2.0–2.5 g; Total dietary fiber 3.0–4.5 g (including mucilage polysaccharides such as rhamnogalacturonan and glucomannan); Fat 0.3–0.5 g; Carbohydrates 8–12 g; Ash 2.0–2.5 g. Minerals: Calcium 180–250 mg, Potassium 250–350 mg, Magnesium 20–50 mg, Iron 1.2–3.5 mg, Zinc 0.5–1.5 mg, Manganese 0.3–0.8 mg, Phosphorus 40–60 mg, Sodium 5–16 mg. Vitamins: Vitamin C (ascorbic acid) 8–33 mg, Vitamin A (as beta-carotene equivalent) 250–450 µg RAE, Vitamin K ~150–200 µg, small amounts of B-vitamins including thiamine (~0.05 mg), riboflavin (~0.1 mg), and niacin (~0.6 mg). Key bioactive compounds: Iridoid glycosides — aucubin (0.3–1.5% dry weight) and catalpol (0.3–1.0% dry weight), which possess anti-inflammatory and antimicrobial properties; bioavailability of aucubin is moderate orally, with hepatic conversion to the active aglycone aucubigenin. Phenylpropanoid glycosides — acteoside (verbascoside, 0.5–3.5% dry weight) and plantamajoside (0.2–1.5% dry weight), potent antioxidants with moderate oral bioavailability limited by ester hydrolysis in the gut. Flavonoids — luteolin, apigenin, and their 7-O-glucosides (total flavonoids ~0.2–0.8% dry weight); luteolin bioavailability is enhanced by glycoside hydrolysis in the intestine. Mucilage polysaccharides (in seeds/husks 10–20% dry weight; in leaves ~2–6% dry weight) — primarily composed of xylose, galacturonic acid, rhamnose, and arabinose residues; act as soluble fiber, not absorbed but fermented by colonic microbiota to produce short-chain fatty acids. Tannins 1–3% dry weight. Organic acids: chlorogenic acid (~0.1–0.4% dry weight), caffeic acid, and fumaric acid. Triterpenes including oleanolic acid and ursolic acid (~0.1–0.5% dry weight). Fatty acid profile of seeds includes alpha-linolenic acid (ALA, omega-3) at approximately 15–25% of seed oil, and linoleic acid (omega-6) at 10–20% of seed oil. Bioavailability notes: The iridoid glycosides require enzymatic activation (beta-glucosidase) for full biological activity; mucilage can slow gastric emptying, potentially affecting absorption kinetics of co-ingested nutrients and drugs; polyphenols (acteoside, plantamajoside) undergo significant first-pass metabolism and phase II conjugation, reducing systemic bioavailability but potentially providing local gastrointestinal antioxidant effects; mineral bioavailability may be modestly reduced by tannin and oxalate content.

Preparation & Dosage

Topical: Ointment/cream applied daily (standardized to quercetin 1.88 mg/100g) for 14 days. Oral seeds: 3600 mg/day for ulcerative colitis (8 weeks); 20 g/day for diabetic nephropathy (60 days); 4 g/day for NAFLD (12 weeks). Syrup: 30 ml/day for acute bronchitis (10 days). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Slippery Elm, Marshmallow Root, Licorice Root, Aloe Vera

Safety & Interactions

Plantago major is generally well-tolerated with minimal reported side effects in clinical studies. Oral consumption may delay absorption of other medications due to mucilage content, so timing separation of 1-2 hours is recommended. Individuals with known allergies to plantain or other Plantaginaceae family plants should avoid use. Pregnancy and breastfeeding safety data is limited, warranting caution during these periods.